The Delusional Misidentification Syndromes
A Continuum of Misidentification SymptomsSno H.N.
University Department of Psychiatry, Academic Medical Centre, Amsterdam, The Netherlands
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
A case study of a schizophrenic patient with differing forms of experiences of inappropriate familiarity is described. Reduplicative paramnesia is redefined as a delusion of familiarity related to a reduplication of time, place or person. The author proposes the concept of a continuum of positive and negative misidentification symptoms. The positive pole of the continuum ranges from the minor form of dÉjÀ vu experience to reduplicative paramnesia. The negative pole ranges from depersonalisation to nihilistic delusions. Differentiation is based on the severity of the disturbance of reality testing. The argumentation is based on the fact that both dÉjÀ vu experiences and depersonalisation occurring in pathological as well as non-pathological conditions are phenomenologically uniform.
© 1994 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.